<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02558699</url>
  </required_header>
  <id_info>
    <org_study_id>4-2015-0646</org_study_id>
    <nct_id>NCT02558699</nct_id>
  </id_info>
  <brief_title>Clinical Usefulness of Virtual Ablation Guided Catheter Ablation of Atrial Fibrillation: Virtual Rotor Mapping and Catheter Ablation</brief_title>
  <acronym>CUVIA-AF II</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Radiofrequency catheter ablation is effective in the treatment of patients with paroxysmal
      atrial fibrillation. In order to reduce the recurrence rate after catheter ablation, we
      propose to apply 'virtual' ablation on patient-specific atria by simulating 3D atrial
      computer model. We will conduct virtual rotor mapping in the patient specific atrial model.
      Then, we will compare the clinical outcome of conventional circumferential pulmonary vein
      isolation and additional rotor ablation guided by virtual rotor mapping.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">August 2019</completion_date>
  <primary_completion_date type="Anticipated">August 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>recurrence rate of atrial fibrillation</measure>
    <time_frame>18 month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>rate of hospitalization</measure>
    <time_frame>24 month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>mortality</measure>
    <time_frame>24 month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>incidence of ischemic cerebral infarction</measure>
    <time_frame>24 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major complication of hemorrhagic and embolic</measure>
    <time_frame>24 month</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Paroxysmal Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>conventional group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group operating the atrial fibrillation by physician's personal experience, not by virtual simulation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3D atrial computer model</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group choosing choose the best effective rotor mapping by simulating 3D atrial computer model which consider patinet's heart size and shape.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>physician's personal experience</intervention_name>
    <arm_group_label>conventional group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Virtual rotor mapping</intervention_name>
    <arm_group_label>3D atrial computer model</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  AF patient age 19~80

          -  Diagnosis of AF patients who performed catheter ablation of atrial fibrillation due to
             uncontrolled pulse rate by anti-arrhythmic drug therapy.

        Exclusion Criteria:

          -  AF patients who have severe heart deformations or vascular disease.

          -  The patient who have renal disease of eGFR&lt;30mL/min

          -  The patients who had been performed catheter ablation of atrial ablation and MAZE.

          -  The patients who missed out to recording of 3D CT, echo and electrocardiography.

          -  the patient have experienced major hemorrhagic complication

          -  The patient have experienced ischemic cerebral infarction more 2 times

          -  The patient who have risk of ischemic cerebral infarction (CHA2DS2-VASc Score &gt;5)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Severance Cardiovascular Hospital, Yonsei University Health System</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hui-Nam Pak, M.D., Ph.D.</last_name>
      <phone>82-2-2228-8459</phone>
      <email>hnpak@yuhs.ac</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 23, 2015</study_first_submitted>
  <study_first_submitted_qc>September 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 24, 2015</study_first_posted>
  <last_update_submitted>September 23, 2015</last_update_submitted>
  <last_update_submitted_qc>September 23, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 24, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

